Aminopyrazoles are privileged molecular cores in drug design that present unique synthetic challenges, particularly when developing direct, site‐selective transition metal‐catalyzed C─H functionalization. Specifically, differentiating between C─H sites while contending with the reactivity of the amine and azinyl components is an unresolved challenge. Here, we describe strategies for the regioselective functionalization of 3‐ and 5‐aminopyrazoles through Ir‐catalyzed C─H borylation, exploiting the interplay between intrinsic reactivities and directing effects that influence C─H activation. The resulting borylated adducts can readily be elaborated to provide a range of arylated aminopyrazoles. Collectively, these studies constitute a general and readily adaptable blueprint for selectively generating isomeric aminopyrazole pharmacophores with tunable product distributions.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: